June 21, 2018 12:39 PM ET


Company Overview of Shire Human Genetic Therapies, Inc.

Company Overview

Shire Human Genetic Therapies, Inc. develops, and commercializes therapeutics for the treatment of genetic diseases caused by protein deficiencies. The company markets and sells Replagal, an enzyme replacement therapy for the long-term treatment of patients with Fabry disease, in 34 countries outside the United States. The company’s primary clinical programs include iduronate-2-sulfatase, an enzyme replacement therapy for the treatment of hunter syndrome, which is in phase III clinical trials; and Gene-Activated glucocerebrosidase, an enzyme replacement therapy for the treatment of Gaucher disease, which is in phase I/ II clinical trials. In addition, the company, in collaboration with Avent...

300 Shire Way

Lexington, MA 02421

United States

Founded in 1988

400 Employees





Key Executives for Shire Human Genetic Therapies, Inc.

Senior Vice President and Franchise Lead of Mucopolysaccharides
Age: 52
Corporate Communications Manager
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
Praetego, Inc. United States
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Shire Human Genetic Therapies, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.